These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 28491151

  • 1. Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis.
    Zheng R, Gao D, He T, Zhang M, Zhang X, Linghu E, Wei L, Guo M.
    Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
    [Abstract] [Full Text] [Related]

  • 2. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
    Wang Y, He T, Herman JG, Linghu E, Yang Y, Fuks F, Zhou F, Song L, Guo M.
    Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
    [Abstract] [Full Text] [Related]

  • 3. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W, Wu K, Herman JG, Xu X, Yang Y, Dai G, Guo M.
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [Abstract] [Full Text] [Related]

  • 4. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
    Gao D, Han Y, Yang Y, Herman JG, Linghu E, Zhan Q, Fuks F, Lu ZJ, Guo M.
    Epigenetics; 2017 Jul 03; 12(7):575-583. PubMed ID: 28678648
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Zhu YH, Fu L, Chen L, Qin YR, Liu H, Xie F, Zeng T, Dong SS, Li J, Li Y, Dai Y, Xie D, Guan XY.
    Cancer Res; 2013 Apr 01; 73(7):2298-309. PubMed ID: 23436800
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic regulation of voltage-gated potassium ion channel molecule Kv1.3 in mechanisms of colorectal cancer.
    He T, Wang C, Zhang M, Zhang X, Zheng S, Linghu E, Guo M.
    Discov Med; 2017 Mar 01; 23(126):155-162. PubMed ID: 28472608
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.
    Hu S, Cao B, Zhang M, Linghu E, Zhan Q, Brock MV, Herman JG, Mao G, Guo M.
    Am J Cancer Res; 2015 Mar 01; 5(2):651-62. PubMed ID: 25973304
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN, Kim SJ, Kim ER, Chang DK, Kim YH.
    J Gastroenterol Hepatol; 2016 Jan 01; 31(1):164-71. PubMed ID: 26250123
    [Abstract] [Full Text] [Related]

  • 9. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M, Peng Y, Wang X, Guo Q, Shen S, Li G.
    BMC Cancer; 2010 Apr 27; 10():160. PubMed ID: 20423473
    [Abstract] [Full Text] [Related]

  • 10. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W, Guan M, Su B, Ye C, Li J, Zhang X, Liu C, Li M, Lin Y, Lu Y.
    Cancer Biol Ther; 2010 Jun 01; 9(11):862-71. PubMed ID: 20364105
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.
    Zhang M, Li X, Herman JG, Gao A, Wang Q, Yao Y, Shen F, He K, Guo M.
    Clin Transl Gastroenterol; 2024 Mar 01; 15(3):e00682. PubMed ID: 38235705
    [Abstract] [Full Text] [Related]

  • 13. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.
    Hu X, Sui X, Li L, Huang X, Rong R, Su X, Shi Q, Mo L, Shu X, Kuang Y, Tao Q, He C.
    J Pathol; 2013 Jan 01; 229(1):62-73. PubMed ID: 22926751
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
    Li H, Zhang M, Linghu E, Zhou F, Herman JG, Hu L, Guo M.
    Clin Epigenetics; 2018 Nov 06; 10(1):137. PubMed ID: 30400968
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
    Piazzi G, Selgrad M, Garcia M, Ceccarelli C, Fini L, Bianchi P, Laghi L, D'Angelo L, Paterini P, Malfertheiner P, Chieco P, Boland CR, Bazzoli F, Ricciardiello L.
    Br J Cancer; 2013 Apr 30; 108(8):1750-6. PubMed ID: 23579212
    [Abstract] [Full Text] [Related]

  • 18. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
    Kano H, Takayama T, Midorikawa Y, Nagase H.
    Biosci Trends; 2016 Jul 19; 10(3):202-9. PubMed ID: 27301432
    [Abstract] [Full Text] [Related]

  • 19. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
    Cao B, Yang W, Jin Y, Zhang M, He T, Zhan Q, Herman JG, Zhong G, Guo M.
    J Thorac Oncol; 2016 Nov 19; 11(11):1912-1926. PubMed ID: 27374455
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.